{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:29:58Z","timestamp":1774279798080,"version":"3.50.1"},"reference-count":136,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Windland Smith Rice Sudden Comprehensive Sudden Cardiac Death Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Gastrointestinal sensorimotor dysfunction underlies a wide range of esophageal, gastric, and intestinal motility and functional disorders that collectively constitute nearly half of all referrals to gastroenterologists. As a result, substantial effort has been dedicated toward the development of prokinetic agents intended to augment or restore normal gastrointestinal motility. However, the use of several clinically efficacious gastroprokinetic agents, such as cisapride, domperidone, erythromycin, and tegaserod, is associated with unfavorable cardiovascular safety profiles, leading to restrictions in their use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose<\/jats:title><jats:p>The purpose of this review is to detail the cellular and molecular mechanisms that lead commonly to drug\u2010induced cardiac arrhythmias, specifically drug\u2010induced long<jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>syndrome, torsades de pointes, and ventricular fibrillation, to examine the cardiovascular safety profiles of several classes of prokinetic agents currently in clinical use, and to explore potential strategies by which the risk of drug\u2010induced cardiac arrhythmia associated with prokinetic agents and other<jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>interval prolonging medications can be mitigated successfully.<\/jats:p><\/jats:sec>","DOI":"10.1111\/nmo.13302","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T05:46:39Z","timestamp":1518587199000},"source":"Crossref","is-referenced-by-count":62,"title":["Cardiovascular safety of prokinetic agents: A focus on drug\u2010induced arrhythmias"],"prefix":"10.1111","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-0265","authenticated-orcid":false,"given":"J. R.","family":"Giudicessi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Ackerman","sequence":"additional","affiliation":[{"name":"Departments of Cardiovascular Medicine, Pediatrics, and Molecular Pharmacology &amp; Experimental Therapeutics Mayo Clinic Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-7514","authenticated-orcid":false,"given":"M.","family":"Camilleri","sequence":"additional","affiliation":[{"name":"Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.) Mayo Clinic Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2008.01084.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI70837"},{"key":"e_1_2_7_4_1","first-page":"1317","article-title":"Prolonged Q\u2010T interval \u2013 what does it mean","volume":"7","author":"Schwartz PJ","year":"1982","journal-title":"J Cardiovasc Med"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(84)80237-4"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450210088038"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(03)00205-7"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.20.1468.34482"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.01.013"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.110"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.063"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2012.3"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.191096"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.661082"},{"key":"e_1_2_7_15_1","first-page":"E440","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement From the American Heart Association and the American College of Cardiology Foundation (vol 121, pg 1047, 2010)","volume":"122","author":"Drew BJ","year":"2010","journal-title":"Circulation"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2010.09.017"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.30.1.17"},{"key":"e_1_2_7_18_1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/jama.1993.03500120051025","article-title":"Terfenadine\u2010ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences","volume":"269","author":"Honig PK","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500120070028"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430070125014"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03927.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.4.817"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.2.204"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.115.3.229"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706892"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.073692"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706143"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003623"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.007765"},{"key":"e_1_2_7_30_1","unstructured":"CredibleMeds.https:\/\/crediblemeds.org\/.2017."},{"key":"e_1_2_7_31_1","unstructured":"Administration USFaD.FDA Adverse Events Reporting System (FAERS) Public Dashboard. 2017;2017."},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(67)80129-X"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01255.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01867.x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.373"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04189.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.300"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2006.12.004"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1159\/000083234"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e31827afd0d"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03189516"},{"key":"e_1_2_7_42_1","first-page":"285","article-title":"Determination of domperidone in human plasma by LC\u2010MS and its pharmacokinetics in healthy Chinese volunteers","volume":"23","author":"Wu MS","year":"2002","journal-title":"Acta Pharmacol Sin"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250400015301"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.2.7"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015666"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi312"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.2165\/11536840-000000000-00000"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2016"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.065"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200911030-00004"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.s1-8.1.51"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01317-4"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02009.x"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2444"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12075"},{"key":"e_1_2_7_56_1","first-page":"G470","article-title":"Erythromycin is a motilin receptor agonist","volume":"257","author":"Peeters T","year":"1989","journal-title":"Am J Physiol"},{"key":"e_1_2_7_57_1","first-page":"121","article-title":"Comparison of the effects of midecamycin acetate and azithromycin on gastrointestinal motility in man","volume":"20","author":"Sifrim D","year":"1994","journal-title":"Drugs Exp Clin Res"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12077"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl537"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1027309703313"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1996.tb03650.x"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.128387"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040582"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706900"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003833"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300799"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.029"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.003560"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.80a.13077"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0190-z"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702665"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703254"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704471"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2005.00621.x"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm020099f"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198836060-00002"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050255"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00241-7"},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200104000-00013"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.02948.x"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6856.748-a"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70409-2"},{"key":"e_1_2_7_83_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/107424849600100309","article-title":"Cardiac arrest associated with combination cisapride and itraconazole therapy","volume":"1","author":"Hoover CA","year":"1996","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15295.x"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)01249-0"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1997.273.5.H2534"},{"key":"e_1_2_7_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70133-5"},{"key":"e_1_2_7_88_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajot.2002.124543"},{"key":"e_1_2_7_89_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.23.3036"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.13.1607"},{"key":"e_1_2_7_91_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00925.x"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05011.x"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2012.11.002"},{"key":"e_1_2_7_94_1","first-page":"1269","article-title":"In vitro metabolism of tegaserod in human liver and intestine: assessment of drug interactions","volume":"29","author":"Vickers AE","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_7_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04785.x"},{"key":"e_1_2_7_96_1","doi-asserted-by":"publisher","DOI":"10.1177\/1074248409340158"},{"key":"e_1_2_7_97_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000703500613"},{"key":"e_1_2_7_98_1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3565(24)36775-8","article-title":"Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?","volume":"282","author":"Carlsson L","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_99_1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)29223-5","article-title":"Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether\u2010a\u2010gogo K(+) channel","volume":"299","author":"Potet F","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-008-0282-y"},{"key":"e_1_2_7_101_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.11.7757"},{"key":"e_1_2_7_102_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.060426"},{"key":"e_1_2_7_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2010.01519.x"},{"key":"e_1_2_7_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e31829196d0"},{"key":"e_1_2_7_105_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.07.035"},{"key":"e_1_2_7_106_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2017.1401117"},{"key":"e_1_2_7_107_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.113.000152"},{"key":"e_1_2_7_108_1","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2014-002896"},{"key":"e_1_2_7_109_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.113.000651"},{"key":"e_1_2_7_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-017-0803-7"},{"key":"e_1_2_7_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3014"},{"key":"e_1_2_7_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.364"},{"key":"e_1_2_7_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.362"},{"key":"e_1_2_7_114_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.111.960930"},{"key":"e_1_2_7_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.01.031"},{"key":"e_1_2_7_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.03.031"},{"key":"e_1_2_7_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.01.015"},{"key":"e_1_2_7_118_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.110.959049"},{"key":"e_1_2_7_119_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.023980"},{"key":"e_1_2_7_120_1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0026-895X(25)09019-4","article-title":"High affinity open channel block by dofetilide of HERG expressed in a human cell line","volume":"49","author":"Snyders DJ","year":"1996","journal-title":"Mol Pharmacol"},{"key":"e_1_2_7_121_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.003655"},{"key":"e_1_2_7_122_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199902000-00002"},{"key":"e_1_2_7_123_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.11.1012"},{"key":"e_1_2_7_124_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.59.1.122"},{"key":"e_1_2_7_125_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.302.1.320"},{"key":"e_1_2_7_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(01)03320-8"},{"key":"e_1_2_7_127_1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3565(24)38946-3","article-title":"Interactions of the 5\u2010hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels","volume":"295","author":"Kuryshev YA","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.10.010"},{"key":"e_1_2_7_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00355-9"},{"key":"e_1_2_7_130_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000109484.00668.CE"},{"key":"e_1_2_7_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2013.04.027"},{"key":"e_1_2_7_132_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0700989"},{"key":"e_1_2_7_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00123-0"},{"key":"e_1_2_7_134_1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0022-3565(24)38082-6","article-title":"Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current","volume":"288","author":"Drolet B","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2014.11.057"},{"key":"e_1_2_7_136_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.038240"},{"key":"e_1_2_7_137_1","doi-asserted-by":"publisher","DOI":"10.1080\/10915810601117992"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnmo.13302","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nmo.13302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:35:04Z","timestamp":1751402104000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nmo.13302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":136,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1111\/nmo.13302"],"URL":"https:\/\/doi.org\/10.1111\/nmo.13302","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,14]]},"article-number":"e13302"}}